$CBUS 4 SEC Filings

Filed On	Filing
10 Jun 2026	Form 4: Wichner Craig, CEO Received 894,309 shares as a grant or award · Granted 1,047,620 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Finn Mark Terrence, Director Granted 77,586 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Moretti August J, Director Granted 77,586 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Riggs Rory B, Director Granted 77,586 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Prante Gerhard, Director Received 64,748 shares as a grant or award
04 Jun 2026	Form 4: Lehmann Jean-Pierre Jules, Director Received 64,748 shares as a grant or award
04 Jun 2026	Form 4: Box Kimberly Ann, Director Granted 77,586 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Wichner Craig, Director Granted 77,586 Stock Option (Right-to-Buy)
04 Jun 2026	Form 4: Urban Thomas, Director Received 64,748 shares as a grant or award
28 Apr 2026	Form 4: Urban Thomas, Director Granted 9,094 Stock Option (Right-to-Buy)
28 Apr 2026	Form 4: Sauer Noel, Sr VP, Research Received 38,000 shares as a grant or award · Granted 76,000 Stock Option (Right-to-Buy)
28 Apr 2026	Form 4: Stokes Jason, CAO, Gen Csl & Corp Secy Received 57,000 shares as a grant or award · Granted 114,000 Stock Option (Right-to-Buy)
28 Apr 2026	Form 4: Broos Carlo, CFO Received 57,000 shares as a grant or award · Granted 114,000 Stock Option (Right-to-Buy)
28 Apr 2026	Form 4: Gocal Gregory Francis William, Chief Scientific Officer & EVP Received 57,000 shares as a grant or award · Granted 114,000 Stock Option (Right-to-Buy)
28 Apr 2026	Form 4: Beetham Peter, Interim CEO, Pres & COO Received 195,000 shares as a grant or award · Granted 390,000 Stock Option (Right-to-Buy)
01 Apr 2026	Form 4: Sauer Noel, Sr VP, Research Gave up 1,763 shares to cover exercise price or tax ($3.24K)
01 Apr 2026	Form 4: Stokes Jason, CLO, Gen Csl & Secy Gave up 3,695 shares to cover exercise price or tax ($6.76K)
01 Apr 2026	Form 4: Broos Carlo, CFO Gave up 3,676 shares to cover exercise price or tax ($6.87K)
01 Apr 2026	Form 4: Gocal Gregory Francis William, Chief Scientific Officer & EVP Gave up 8,954 shares to cover exercise price or tax ($16.3K)
01 Apr 2026	Form 4: Beetham Peter, Director Gave up 16,112 shares to cover exercise price or tax ($29.8K)

Comments